Biochemistry

IGI researchers, including Bruce Conklin of UCSF and Jennifer Doudna of UC Berkeley, discuss the promise of CRIRSP-Cas9 'genome surgery.'

The Court of Appeals today concluded that the use of CRISPR-Cas9 in plant and animal cells is separately patentable from Drs. Doudna and Charpentier's invention of the use of CRISPR-Cas9 in any environment. We are evaluating further litigation options. We also look forward to proving that Drs. Doudna and Charpentier first invented usage in plant and animal cells – a fact that is already widely recognized by the global scientific community – as the Doudna-Charpentier team's several pending patent applications that cover use of CRISPR-Cas9 in plant and animal cells are now under examination by the patent office.

John Casida, one of the world's leading authorities on how pesticides work and how they can potentially harm humans. Casida was the founding director of the campus's Environmental Chemistry and Toxicology Laboratory.

The collaborators hope new advances in chemical biology could open up the human proteome.